ASX:MVP

Bell Potter

In this report, our analysts share their sector view and top stock picks for 2018 across sectors including banks and general insurers, diversified financials, LICs, fixed income, agricultural FMCG, technology, discretionary retail, industrials, resources, and healthcare & biotech. Show More

Join the conversation
Mathan Somasundaram

Local market bounced back on positive US and China economic data. The local business capex outlook data was positive but the weak consumer sentiment shows that one has not translated to the other since GFC. The GDP growth rate hit 3% and maintains the recovery pace we have seen in... Show More

Bell Potter

In this report, our analyst team share their top stock picks for FY18, and also provide their sector outlook. On Financials, TS Lim reports that "There is something for everyone in Show More

Bell Potter

In this report, ten of our analysts share their top stock picks for 2017, as well as providing their sector outlook. On Financials, TS Lim reports that “The 2016 reporting season suggests underlying fundamentals are becoming positive for the banks. These include slowing margin decline as competition for new customers... Show More

Mathan Somasundaram

Whilst global markets have maintained positive momentum into 2017, valuations look stretched. Markets are going to run into the US reporting season given the US leadership change and the recent rally pricing due to the optimistic outlook. However, US fiscal policy uncertainty, historically low volatility, rising USD, rising yields and... Show More

Mathan Somasundaram

Global markets are flip flopping with the US market hitting all time highs. US fiscal policy uncertainty, historically low volatility, a rising USD, rising yields and stretched valuations are raising doubts on the recent exuberance in the equity market. Strong commodities along with a robust USD and rising yields suggests... Show More

Livewire Exclusive

For the first three months of 2016 the ASX 200 has delivered a negative 4% return. Weakness in the major index constituents continues to weigh on many investor portfolios. However, there remains a subset of companies that continue to thrive - delivering opportunity for the active investor. Livewire reached out... Show More

Wilson Asset Management

Medical Developments International (ASX: MVP) announced this week it received final approval from the Health Products Regulatory Authority of the Republic of Ireland to market and sell its inhaled pain-relief product Penthrox. The company said the approval gives MVP’s partner in Ireland and the United Kingdom, Galen, the opportunity to... Show More